Cardinal Health Inc (NYSE:CAH) was upgraded by investment analysts at Goldman Sachs from a “buy” rating to a “conviction-buy” rating in a report released on Monday, The Fly reports.
Several large investors have recently added to or reduced their stakes in CAH. HighPoint Advisor Group LLC purchased a new stake in Cardinal Health during the fourth quarter worth about $265,000. BKD Wealth Advisors LLC purchased a new stake in Cardinal Health during the fourth quarter worth about $286,000. Coastline Trust Company purchased a new stake in Cardinal Health during the fourth quarter worth about $412,000.
Source: American Banking and Market News